7 completed, 1 unknown. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo Desogestrel Oral Tablet - Endometrioma | Phase 2 / Phase 3 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 20 | 2021-06-01 | 2022-10-31 |
| Optimisation of Follicular Recruitment in IVM Cycles blood sampling, transvaginal ultrasound scanning, oocyte retrieval for IVM - Infertility, Female, Polycystic Ovary Syndrome | Phase 3 | Completed | Universitair Ziekenhuis Brussel | 145 | 2017-11-01 | 2023-04-07 |
| Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB Desogestrel, Medroxyprogesterone acetate - Dysfunctional Uterine Bleeding | Phase 3 | Unknown | Mahidol University | 160 | 2013-08-01 | 2018-08-22 |
| Assessment of Desogestrel in Ondine Syndrome desogestrel - Ondine Syndrome | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 6 | 2011-04-01 | 2013-11-14 |
| Comparative Trial in Hormone Withdrawal Associated Symptoms EE20/DRSP (YAZ, BAY86-5300), Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon) - Oral Contraceptive | Phase 3 | Completed | Bayer | 592 | 2010-04-01 | 2014-10-28 |
| Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes Transdermal 17Beta-estradiol, progesterone, Ethinyl Estradiol + Desogestrel, Sham Comparator - Exercise-related Amenorrhea | Phase 3 | Completed | Massachusetts General Hospital | 121 | 2009-05-01 | 2021-06-11 |
| A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021 DR-1021, Mircette®, Kariva® - Healthy | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 61 | 2007-10-31 | 2021-11-18 |
| A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception Yasmin, Marvelon - Contraception | Phase 3 | Completed | Bayer | 842 | 2003-11-01 | 2009-01-14 |
Amenorrhea (1) · Bone Diseases, Metabolic (1) · Endometriosis (1) · Infertility, Female (1) · Metrorrhagia (1) · Osteoporosis (1) · Polycystic Ovary Syndrome (1) · Sleep Apnea, Central (1)
Bayer (2) · Assistance Publique - Hôpitaux de Paris (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · Mahidol University (1) · Massachusetts General Hospital (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · Universitair Ziekenhuis Brussel (1)
Thailand (3) · United States (2) · Argentina (1) · Belgium (1) · Chile (1) · China (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Philippines (1) · Portugal (1) · Russia (1) · South Korea (1)
Madhusmita Misra, MD, MPH (1) · Manee Rattanachaiyanont, M.D. (1) · Ratchadaporn Roekyindee, MD (1)
PMID 21801857, PMID 21816790, PMID 22252944, PMID 25268234, PMID 28297591, PMID 30301734, PMID 30476179, PMID 30639922, PMID 31603998, PMID 35102226, PMID 38336689
2009 (1), R01HD060827 (1)